Related Experiment Video

Updated: May 30, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma

Rajae Dahmani1, Pierre-Alexandre Just, Christine Perret

  • 1U.1016 Inserm, Institut Cochin, CNRS UMR8104, University Paris-Descartes, 24, rue du Faubourg-Saint-Jacques, 75014 Paris, France.

Clinics and Research in Hepatology and Gastroenterology
|July 23, 2011
PubMed

Insights

Hepatocellular carcinoma (HCC), a deadly cancer, involves the Wnt/β-catenin pathway. Inhibiting this pathway shows anti-tumoral effects in cell lines, but clinical trials are lacking.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hepatology

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
  • Targeted therapies for HCC are limited, despite its poor prognosis.
  • The Wnt/β-catenin signaling pathway is frequently deregulated in HCC and implicated in liver cancer development.

Purpose of the Study:

  • To review the role of the Wnt/β-catenin pathway in hepatocellular carcinoma pathogenesis.
  • To discuss the potential benefits of targeting this pathway for HCC treatment.
  • To outline the limitations of Wnt pathway-targeted therapies in HCC.

Main Methods:

  • Literature review of studies on Wnt/β-catenin signaling in HCC.
  • Analysis of existing data on the anti-tumoral effects of Wnt pathway inhibition.
  • Evaluation of current challenges and future directions for clinical applications.

Main Results:

  • The Wnt/β-catenin pathway is crucial for hepatic oncogenesis.
  • Inhibition of β-catenin signaling demonstrates anti-tumoral activity in HCC cell lines.
  • No Wnt pathway-targeting drugs are currently in clinical trials for HCC.

Conclusions:

  • Targeting the Wnt/β-catenin pathway holds promise for HCC treatment.
  • Further research is needed to overcome limitations and advance clinical translation.
  • Understanding the pathway's role is key to developing effective HCC therapies.

More Related Videos

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...